Atlas Trials

PROstate Cancer TReatment Optimization Via Analysis of Circulating Tumour DNA

Clinical trial NCT04015622 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04015622
Sponsor
British Columbia Cancer Agency
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Start date
2020-10-07
Primary completion
2026-04-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.